November 15, 2023

FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This Medical News article discusses the November 8 US Food and Drug Administration approval of the drug tirzepatide for chronic weight management in people with obesity or overweight with weight-related conditions.

Me gusta

Guardar

Cite This Study

Jennifer Abbasi (Wed,) studied this question.

synapsesocial.com/papers/69dabb0a4e9a02dbaa6840ff https://doi.org/https://doi.org/10.1001/jama.2023.24539

Me gusta

Guardar